1. Home
  2. BEAM vs YELP Comparison

BEAM vs YELP Comparison

Compare BEAM & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$26.19

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$31.11

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
YELP
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
BEAM
YELP
Price
$26.19
$31.11
Analyst Decision
Strong Buy
Hold
Analyst Count
12
5
Target Price
$48.09
$32.00
AVG Volume (30 Days)
1.9M
1.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.30
EPS
N/A
2.25
Revenue
$55,701,000.00
$1,466,918,000.00
Revenue This Year
N/A
$5.87
Revenue Next Year
$26.52
$2.94
P/E Ratio
N/A
$13.78
Revenue Growth
N/A
5.34
52 Week Low
$13.53
$27.29
52 Week High
$35.25
$41.72

Technical Indicators

Market Signals
Indicator
BEAM
YELP
Relative Strength Index (RSI) 53.22 60.45
Support Level $25.53 $30.04
Resistance Level $27.87 $30.94
Average True Range (ATR) 1.67 0.67
MACD -0.03 0.27
Stochastic Oscillator 49.36 89.69

Price Performance

Historical Comparison
BEAM
YELP

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

Share on Social Networks: